TRANSMEDICS GROUP INC (TMDX)

US89377M1099 - Common Stock

76.17  -3.17 (-4%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

TRANSMEDICS GROUP INC

NASDAQ:TMDX (11/22/2024, 11:43:50 AM)

76.17

-3.17 (-4%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-43.45%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap2.56B
Shares
PE81.03
Fwd PE45.17
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

TMDX Daily chart

Company Profile

TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 584 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Company Info

TRANSMEDICS GROUP INC

200 Minuteman Road

Andover MASSACHUSETTS 01810

P: 19785520900

CEO: Waleed H. Hassanein

Employees: 584

Website: https://www.transmedics.com/

TMDX News

News Image3 days ago - TransMedics Group, Inc.TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference

/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...

News Image7 days ago - The Motley FoolIs TransMedics Group Stock a Buy?

This organ transplant specialist is down, but still has plenty of signs of life.

News Image13 days ago - The Motley FoolDown 52%, Is TransMedics Stock a Buy on the Dip?

Sales growth is tapering off for this provider of delivery services for transplant organs.

News Image15 days ago - Scott+Scott Attorneys at Law LLPScott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX)
News Image15 days ago - The Motley FoolWhy TransMedics Stock Plunged in October

The organ transplant specialist posted disappointing results in its third-quarter report.

News Image18 days ago - The Motley Fool1 Top Growth Stock Down 50% to Buy After Its Recent Pullback

TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity.

TMDX Twits

Here you can normally see the latest stock twits on TMDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example